Literature DB >> 21531476

CD8α⁺ dendritic cells improve collagen-induced arthritis in CC chemokine receptor (CCR)-2 deficient mice.

Jessica M Ibarra1, Marlon P Quinones, Carlos A Estrada, Fabio Jimenez, Hernan G Martinez, Seema S Ahuja.   

Abstract

OBJECTIVE: Dendritic cells (DCs) have long been recognized as potential therapeutic targets of rheumatoid arthritis (RA). Increasing evidence has showed that DCs are capable of suppressing autoimmunity by expanding FoxP3⁺ regulatory T cells (T(reg)), which in turn exert immunosuppression by increasing TGFβ-1. In the SKG mice, activated DC prime autoreactive T cells causing autoantibody production and an inflammatory arthritic response. Recently, we reported that CC-chemokine receptor-2 deficient (Ccr2⁻/⁻) mice had impaired DCs migration and reduced CD8α⁺ DCs in the C57Bl/6J mice strain and that these mice were more susceptible to collagen antibody-induced arthritis (CAIA), compared to wild type mice. To examine the mechanism by which DCs contribute to the increased susceptibility of arthritis in Ccr2⁻/⁻ mice, we tested the hypothesis that CD8α⁺ DCs are protective (tolerogenic) against autoimmune arthritis by examining the role of CD8α⁺ DCs in Ccr2⁻/⁻ and SKG mice.
METHODS: To examine the mechanism by which DCs defects lead to the development of arthritis, we used two murine models of experimental arthritis: collagen-induced arthritis (CIA) in DBA1/J mice and zymosan-induced arthritis in SKG mice. DBA1/J mice received recombinant fms-like tyrosine kinase 3 ligand (Flt3L) injections to expand endogenous DCs populations or adoptive transfers of CD8α⁺ DCs.
RESULTS: Flt3L-mediated expansion of endogenous CD8α⁺ DCs resulted in heightened susceptibility of CIA. In contrast, supplementation with exogenous CD8α⁺ DCs ameliorated arthritis in Ccr2⁻/⁻ mice and enhanced TGFβ1 production by T cells. Furthermore, SKG mice with genetic inactivation of CCR2 did not affect the numbers of DCs nor improve the arthritis phenotype.
CONCLUSION: CD8α⁺ DCs were tolerogenic to the development of arthritis. CD8α⁺ DCs deficiency heightened the sensitivity to arthritis in Ccr2⁻/⁻ mice. Ccr2 deficiency did not alter the arthritic phenotype in SKG mice suggesting the arthritis in Ccr2⁻/⁻ mice was T cell-independent. Published by Elsevier GmbH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21531476      PMCID: PMC3426926          DOI: 10.1016/j.imbio.2011.03.012

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  30 in total

1.  Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells.

Authors:  Li Wang; Karina Pino-Lagos; Victor C de Vries; Indira Guleria; Mohamed H Sayegh; Randolph J Noelle
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-02       Impact factor: 11.205

2.  Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.

Authors:  O Akbari; R H DeKruyff; D T Umetsu
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

Review 3.  The complex role of the chemokine receptor CCR2 in collagen-induced arthritis: implications for therapeutic targeting of CCR2 in rheumatoid arthritis.

Authors:  Marlon P Quinones; Carlos A Estrada; Yogeshwar Kalkonde; Sunil K Ahuja; William A Kuziel; Matthias Mack; Seema S Ahuja
Journal:  J Mol Med (Berl)       Date:  2005-04-13       Impact factor: 4.599

4.  Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice.

Authors:  Meredith O'Keeffe; Hubertus Hochrein; David Vremec; Joanne Pooley; Robert Evans; Susan Woulfe; Ken Shortman
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

Review 5.  Dendritic cells in rheumatoid arthritis: Which subset should be used as a tool to induce tolerance?

Authors:  Maria Cristina Lebre; Paul Peter Tak
Journal:  Hum Immunol       Date:  2009-02-21       Impact factor: 2.850

6.  CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells.

Authors:  Sayuri Yamazaki; Diana Dudziak; Gordon F Heidkamp; Christopher Fiorese; Anthony J Bonito; Kayo Inaba; Michel C Nussenzweig; Ralph M Steinman
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

7.  Expansion of peripheral naturally occurring T regulatory cells by Fms-like tyrosine kinase 3 ligand treatment.

Authors:  Lee Kim Swee; Nabil Bosco; Bernard Malissen; Rhodri Ceredig; Antonius Rolink
Journal:  Blood       Date:  2009-02-10       Impact factor: 22.113

8.  Isolation of dendritic cells.

Authors:  K Inaba; W J Swiggard; R M Steinman; N Romani; G Schuler
Journal:  Curr Protoc Immunol       Date:  2001-05

Review 9.  Dendritic cells as targets for therapy in rheumatoid arthritis.

Authors:  Shaukat Khan; Jeffrey D Greenberg; Nina Bhardwaj
Journal:  Nat Rev Rheumatol       Date:  2009-10       Impact factor: 20.543

10.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

View more
  2 in total

Review 1.  Dendritic cell migration in health and disease.

Authors:  Tim Worbs; Swantje I Hammerschmidt; Reinhold Förster
Journal:  Nat Rev Immunol       Date:  2016-11-28       Impact factor: 53.106

2.  Fms-like tyrosine kinase 3 ligand controls formation of regulatory T cells in autoimmune arthritis.

Authors:  Mattias N D Svensson; Sofia E M Andersson; Malin C Erlandsson; Ing-Marie Jonsson; Anna-Karin H Ekwall; Karin M E Andersson; Anders Nilsson; Li Bian; Mikael Brisslert; Maria I Bokarewa
Journal:  PLoS One       Date:  2013-01-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.